CONTROVERSIES IN GENITOURINARY TUMORS

• GIUSEPPE PROCOPIO· RESP. PROGRAMMA PROSTATA IST NAZIONALE TUMORI

• BARBARA AVUZZI· MODERATORE
• ALFREDO BERRUTI· MODERATORE
• SERGIO BRACARDA· MODERATORE
• AMILCARE BRAMBILLA· MODERATORE
• ALBERTO BRIGANTI· MODERATORE
• SEBASTIANO BUTI· MODERATORE
• ORAZIO CAFFO· MODERATORE
• FABIO CALABRO'· RELATORE
• MARIO CATANZARO· MODERATORE
• STEFANO CICCARELLI· MODERATORE
• MELANIE CLAPS· RELATORE
• FILIPPO DE BRAUD· MODERATORE
• UGO DE GIORGI· RELATORE
• MASSIMO DI MAIO· RELATORE
• MARILENA DI NAPOLI· MODERATORE
• ELENA FARE'· MODERATORE
• ANDREA RICCARDO FILIPPI· MODERATORE
• EDOARDO FIORINI· MODERATORE
• LUIGI FORMISANO· MODERATORE
• GIUSEPPE FORNARINI· MODERATORE
• PATRIZIA GIANNATEMPO· RELATORE
• VALENTINA GUADALUPI· RELATORE
• DANIEL HENG· RELATORE
• BARBARA JERECZEK· MODERATORE
• MARCO MARUZZO· MODERATORE
• GIULIA MARVASO· MODERATORE
• CRISTINA MASINI· MODERATORE
• FRANCESCO MASSARI· MODERATORE
• SEBASTIANO NAZZANI· MODERATORE
• ANDREA NECCHI· RELATORE
• CHARLES NGUYEN· RELATORE
• NICOLA NICOLAI· MODERATORE
• CINZIA ORTEGA· MODERATORE
• FRANCO PERRONE· MODERATORE
• GIUSEPPE PROCOPIO· MODERATORE
• GIANCARLO PRUNERI· RELATORE
• RICCARDO RICOTTA· MODERATORE
• SABRINA ROSSETTI· MODERATORE
• SARAH SCAGLIARINI· MODERATORE
• MARCO STELLATO· RELATORE
• CLAUDIO TALMELLI· MODERATORE
• CLAUDIA UNGARELLI· MODERATORE
• YUKSEL URUN· RELATORE
• ELENA VERZONI· MODERATORE
• ELISA ZANARDI· MODERATORE

Ragione sociale

IDEA-Z PROJECT IN PROGRESS

Stato accreditamento

STANDARD - 1° rinnovo

Di sistema

Management of advanced genitourinary malignancies has undergone a major transformation in recent years, due to the advent of novel targeted and immunotherapeutic options. The current treatment scenario continue to expand providing new standards of care that require an increasingly complex and challenging management of patients. Assessment of treatment-related risk and benefits is required and a better knowledge of clinical and molecular features of these diseases is strongly warranted. Results from ongoing studies and validation of predictive/prognostic biomarkers are expected to provide more treatment options and improve outcomes of patients affected by genitourinary malignangies. During this meeting the most recent advances in medical treatment of genitourinary malignancies will be discussed to guide optimal integration of evidence into practice

#1Applicazione nella pratica quotidiana dei principi e delle procedure dell'evidence based practice (EBM - EBN - EBP)

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

100

Verifica presenza

Firma Di Presenza

Verifica apprendimento

Questionario A Risposta Multipla